Isofol Medical AB (publ) (STO:ISOFOL)
Sweden · Delayed Price · Currency is SEK 0.7620
-0.0060 (-0.78%)
Sep 2, 2026, 5:29 PM CET
Isofol Medical AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
244.21M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 721.00K | -12.08M | -94.37% |
| Dec 31, 2022 | 12.80M | -9.61M | -42.89% |
| Dec 31, 2021 | 22.41M | -14.73M | -39.66% |
| Dec 31, 2020 | 37.14M | 37.03M | 34,607.48% |
| Dec 31, 2019 | 107.00K | - | - |
| Dec 31, 2018 | - | - | - |
| Dec 31, 2017 | 227.00K | -281.00K | -55.31% |
| Dec 31, 2016 | 508.00K | 321.00K | 171.66% |
| Dec 31, 2015 | 187.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sprint Bioscience AB | 138.95M |
| Nanologica AB | 136.17M |
| Xbrane Biopharma AB | 83.30M |
| IRLAB Therapeutics AB | 79.33M |
| Intervacc AB | 18.11M |
| Corline Biomedical AB | 11.85M |
| Abera Bioscience AB | 9.10M |
| Elicera Therapeutics AB | 7.79M |
Isofol Medical AB News
- 8 days ago - Isofol Medical AB Quarterly report: Q2 2026 - Filings
- 3 months ago - Isofol Medical AB Quarterly report: Q1 2026 - Filings
- 5 months ago - Isofol Medical AB Slides: FY 2026 - Filings
- 5 months ago - Isofol Medical AB Slides: Corporate presentation - Filings
- 6 months ago - Isofol Medical AB Annual report: Q4 2025 - Filings
- 6 months ago - Isofol Medical AB Quarterly report: Q4 2025 - Filings
- 7 months ago - Isofol Medical AB Slides: Corporate presentation - Filings
- 9 months ago - Isofol Medical AB Slides: ABGSC Investor Days - Filings